Accuray reported $97.84M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Accuray ARAY:US $ 97.84M 25.36M
Atricure ATRC:US $ 28.14M 15.51M
Boston Scientific BSX:US $ 325M 1600M
Cardiovascular Systems CSII:US $ 66.95M 1.09M
Cryolife CRY:US $ 51.41M 3.6M
Edwards Lifesciences EW:US $ 1030.9M 168.1M
Hologic HOLX:US $ 2290.8M 870M
Inogen INGN:US $ 213.4M 22.12M
Mesa Laboratories MLAB:US $ 51.71M 226.59M
Natus Medical BABY:US $ 84.28M 8.69M
Orthofix International OFIX:US $ 71.92M 15.93M
Surmodics SRDX:US $ 24.71M 1.94M
Tandem Diabetes Care TNDM:US $ 93.68M 22.5M